Life's Full Court appeal accepted
Friday, 15 August, 2008
The Full Court of the Federal Court of Australia has accepted an appeal lodged by distressed plasma business Life Therapeutics [ASX: LFE] in the company's ongoing legal battle with Bell IXL.
The court ordered today that the case be sent back to the courts for a retrial.
The ruling states that the judge erred in reaching his conclusion as he failed to establish or at least spell out a chain of evidence which supported an aspect of the plaintiff's allegations.
Bell IXL has been trying to mount a hostile takeover of Life, and alleged that the decision by Life to sell shares to a third company, Aegis Partners, was an attempt by the current directors to retain control of the company.
But according to Life the decision was merely part of a routine capital raising that had been planned since before Bell IXL mounted its takeover campaign.
The initial Federal Court ruling found for Bell, but it has been overturned.
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
